SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " Dru " 2,050 found 🔀 AI-powered Shuffle
An entirely new kind of drug will help us treat the untreatable
The first of a new generation of drugs that works in a completely different way to existing ones has been approved. Columnist Michael Le Page says this approach could transform treatments for all kinds of conditions
National Survey on Drug Use and Health shows promising trends for youth mental health and drug use
A key U.S. government report on mental health, substance use and addiction shows continued improvements in several metrics, especially among young people
Federal survey shows promising trends for youth mental health and drug use
A key U.S. government report on mental health, substance use and addiction shows continued improvements in several metrics, especially among young people.
Federal survey shows promising trends for youth mental health and drug use
A key U.S. government report on mental health, substance use and addiction shows continued improvements in several metrics, especially among young people
Federal survey shows promising trends for youth mental health and drug use
A key U.S. government report on mental health, substance use and addiction shows continued improvements in several metrics, especially among young people
Antibiotic recalled after cardboard particles found in solution
Patients given the drug in question could face an increased risk of blood vessel blockages or inflammation.
Biodegradable implant can deliver targeted cancer immunotherapy while protecting healthy tissue
Scientists at Houston Methodist Research Institute have developed a biodegradable implant designed to deliver cancer-fighting immunotherapy drugs directly into tumors over an extended period, a strategy ...
National Survey on Drug Use, Mental Health
RDML. Christopher Jones, SAMHSA Acting Director, joins the show to talk about the recent SAMHSA survey.
Peptides are the latest wellness trend – but do they work?
A drug advisory committee in the US has recommended approval for several experimental peptides. But there have been no large-scale tests of these new compounds in humans, finds columnist Grace Wade
Pharma’s drug spending deflection
Job lock, surging prescription drug costs, No Surprises Act update, and more from STAT's Health Care Inc.
2026 Baseball Hall of Fame induction: Carlos Beltrán, Andruw Jones, Jeff Kent speak of national, organizational pride while enshrined
Carlos Beltrán, Andruw Jones and Jeff Kent inducted into Baseball Hall of Fame
The National Baseball Hall of Fame officially welcomed three new members into its prestigious institution.
Drug-Resistant Superbugs May Be Jumping Between Pets And Humans, Scientists Warn
Livestock aren't the only issue.
High drug prices anger the public. Steep hospital costs elicit yawns. Why is that?
How is it that pharma companies—and, by extension, health insurers that cover drugs—have targets on their backs while hospitals live like wallflowers?
Synth historian Oli Freke will spend big on a good bicycle
He’s hard at work on the upcoming Beat Gems, a gorgeous coffee-table book about the history of drum machines.
Some people are getting shut out when it comes to GLP-1 drugs. Here’s why.
People with obesity in the United States are being sorted between haves and have-nots.
‘Ozempic face’ and hair loss: what evidence is there for weight-loss drug side-effects?
Research into GLP-1 medications is not always robust but complaints such as digestive problems are well known
Oral GLP-1 drugs may quiet the brain’s food craving circuit
Newer oral drugs related to semaglutide medications such as Ozempic reduced pleasure-driven eating in mice by quieting a deep brain reward circuit. The finding could open new avenues for understanding food cravings and potentially treating substance use disorder.
Matt Mindrum: Don’t put a moratorium on Indianapolis’ growth
Marion County's data center moratorium sends a message that Indianapolis is becoming less open to business. It risks turning away billions in investment from some of the world’s fastest-growing industries.
ACC shares updated recommendations for managing HFpEF
A team of specialists detailed new data and recent breakthroughs in the diagnosis, management and treatment of heart failure with preserved ejection fraction.
FDA panel votes to loosen restrictions for controversial peptides
The vote marks a win for Health Secretary Robert F Kennedy who has said he's a big fan of the drugs, which haven't been well studied for human use.
U.S. health officials investigate new outbreak of parasite cyclospora
The Food and Drug Administration has not yet identified which products are linked to the illnesses.
Barren woman arrested, accused of selling marijuana at her business
A Barren County woman was arrested Wednesday on suspicion of illegally selling marijuana from her business. Agents with the Barren River Drug Task Force and inspectors with the Kentucky Department […]
Harvard Pilgrim, Tufts Health Plan CEO talks GLP-1 weigh-loss drug coverage
A year in, Point32Health CEO sits down to discuss insurance premiums, drug prices, and layoffs.
Federal government to spend $5B on AI-powered health, infrastructure research
More than 15 federal agencies will use AI to investigate the root causes of chronic diseases, develop treatments for pediatric cancer, expedite the discovery of prescription drugs and enhance U.S. energy infrastructure, among other related…
RELEASE: Gottheimer Hosts Telephone Town Hall to Discuss Health Care Costs, Medicare, Social Security, Utility Prices, Affordability in Jersey
Above: Gottheimer conducts a Telephone Town Hall with North Jersey families. WASHINGTON, D.C. — Last night, July 22, 2026, U.S. Congressman Josh Gottheimer (NJ-5) hosted a Telephone Town Hall with thousands of North Jersey residents to discuss his bipartisan efforts to lower health care and prescription drug costs, protect Social Security and Medicare, cut taxes, lower […]
Knicks Big Man Questions NBA 2K’s Victor Wembanyama Decision
On Wednesday, July 22, NBA 2K released the cover athletes for NBA 2K27. Representing today’s NBA will be San Antonio Spurs center Victor Wembanyama. Shortly after the Wemby reveal, New York Knicks center Andre Drummond took to X to question the decision behind having Wembanyama–and not Jalen Brunson–as the cover selection. Knicks Big Man Questions […] The post Knicks Big Man Questions NBA 2K’s Victor Wembanyama Decision appeared first on HEAVY.
Common Weight Loss Drugs Have Been Linked to a Higher Risk of Hair Loss
Here are the stats.
Officials: Barren County business owner arrested, charged with trafficking drugs out of storefront
Law enforcement agencies served a search warrant that led to a drug trafficking arrest.
Why aren’t health insurers rushing to cover GLP-1 prescriptions for beneficial weight loss?
In theory, GLP-1 receptor agonist drugs like semaglutide and tirzepatide should save a lot of money for the health insurers that pay for them. As it turns out, the lived reality is not keeping pace with the idealistic expectation.
Australian woman gives birth to identical quadruplet girls, a medical rarity
The chance of conceiving monozygotic quadruplets is 1 in 15 million, a maternal fetal specialist said.
FDA sees early promise in new gene therapy for BAG3-associated DCM
An investigational drug therapy from Affinia Therapeutics has secured the FDA's orphan drug designation. This means the company now has access to certain benefits, including tax credits and fee exemptions, as it works toward approval.
Biotech experts want FDA drug reviews based on science, not politics
Biotech experts call for the FDA to prioritize scientific expertise over political influence in drug reviews amid recent leadership changes and staffing challenges.
Health Committee advances Collins’ insulin price cap over GOP objections - Live Updates
The bill would limit the private insurance price for the diabetes drug to $35. Its approval by the GOP-led panel was highly unusual.
Samsung Biologics: geographic diversification is a sound business decision
Samsung Biologics has been on a steep upward growth trajectory since receiving its first licence to produce biologic drug substances in 2015.
Wyss Institute receives Massachusetts Life Science Center award to advance metabolomics and lipidomics research across Massachusetts ecosystem
By Benjamin Boettner (BOSTON) — The Wyss Institute at Harvard University has received an award from the Massachusetts Life Science Center (MLSC), enabling it to host a next-generation metabolomics and lipidomics analytical platform. The platform will allow its researchers to creatively pursue new approaches to biomarker and drug discovery across multiple health challenges the Institute...
US to spend $5 billion on health, construction research powered by AI
Agencies will use the funding to identify the root causes of chronic diseases, accelerate drug discovery, develop longer-lasting building materials.
NeuroSense Advances PrimeC Toward New Drug Submission to Health Canada for ALS
/PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-stage clinical biotechnology company focused on developing disease-modifying...
Large Sterling Heights police operation swarms SW Detroit business
Also at the scene was the Drug Enforcement Agency, K-9 police units and officers wearing tactical fatigues and helmets.
Biotech experts want FDA drug reviews based on science, not politics
Biotech experts and industry executives are calling plans by the U.S. Food and Drug Administration — hit by job cuts last year — to hire thousands of employees and update clinical-trial standards encouraging, but want assurance that politics will not interfere in the agency's drug-review process.
Biotech experts want FDA drug reviews based on science, not politics
Biotech experts and industry executives are calling plans by the U.S. Food and Drug Administration — hit by job cuts last year — to hire thousands of employees and update clinical-trial standards encouraging, but want assurance that politics will not interfere in the agency's drug-review process.
Biotech experts want FDA drug reviews based on science, not politics
July 22 (Reuters) - Biotech experts and industry executives are calling plans by the U. Food and Drug Administration — hit by job cuts last year — to hire thousands of employees and update clinical-trial standards encouraging, but want assurance that politics will not interfere in the agency's drug-review process.
Does the science of peptides live up to the hype?
Synthetic peptides are getting some serious hype, from fitness influencers on your FYP to people seeking new options for chronic conditions. And while the human body already makes peptides, like insulin and the hormone oxytocin, most of the viral synthetic peptides are not approved by the Food and Drug Administration. Scientists say that raises some big concerns about safety and efficacy. So ahead of this week’s FDA meeting to discuss seven commonly used peptides, we get into the science with health reporter Sarah Boden.Interested in more science behind health trends? Email us your question at shortwave@npr.org.Support public media with NPR+ and enjoy perks for over 25 podcasts like this one. It includes perks like bonus episodes, early access, archive access, curated playlists and sponsor-free listening. Learn more at plus.npr.org.
An Australian woman gives birth to rare identical quadruplet girls
An Australian woman has given birth to identical quadruplet girls after a pregnancy doctors described as incredibly rare
DEA agents conduct operation at West Knoxville business
KNOXVILLE, Tenn. (WATE) — Federal drug investigators were spotted at a business in West Knoxville on Tuesday. A spokesperson for the Louisville Field Division of the Drug Enforcement Administration…
Attempted kidnapping, break-in at day care likely tied to mental health issues, docs say
Two separate incidents, which according to court documents, are likely related to mental health issues and drug psychosis.
There’s a right way to regulate drugs. Kratom is no exception.
Kratom, social media use in teens, New York's data center moratorium and more, in readers' eyes.
Automated Neurofeedback: Rewiring the Future of Mental Health Care
Mental health and addiction disorders continue to rise across the United States, affecting veterans, adolescents, families, first responders, and entire communities. According to the National Institute on Drug Abuse, nearly half of individuals with a substance use disorder also experience a co-occurring mental health condition. At the same time, healthcare systems are struggling with workforce ...
WVU Health leadership failed to address painkiller thefts as opioids devastated West Virginia
WVU Health Systems has entered into a federal settlement for failing to report and prevent drug thefts by employees.
FDA’s Home as a Health Care Hub Initiative and the READI-Home Innovation Challenge: Key Takeaways for Device Sponsors
Key Takeaways The U.S. Food and Drug Administration’s (FDA’s) Center for Devices and Radiological Health (CDRH) opened its READI-Home Innovation Challenge, offering up to nine device sponsors early,…
Anthropic's life sciences plans: Mystery programs, Nobel hires, M&A and big ambition
Anthropic pushes into life sciences with a $400M Coefficient Bio deal, Nobel hire John Jumper, Claude Science launch and its own drug pipeline.
The next step of site-neutral, and a fiery PBM hearing
Medicare proposes to reduce payments to hospitals for certain drugs and imaging services.
Need surgery or prescriptions? How to deal with prior authorization challenges
Prior authorization: Why insurers require approval for some drugs, tests and procedures.
New Poll: 94% of Americans Say Congress Must Act on Health Care Costs, as Families USA Convenes Bipartisan Policy Symposium
Both House and Senate committees are marking up legislation on hospital price transparency, prescription drug and Medicare Advantage reform. WASHINGTON, D.C. – A new national poll shows that 94% of Americans believe it is important for the President and Congress to take action to lower health care costs. The poll was commissioned by Families USA, […]
Bristol Myers Squibb Building Life Science Industry’s Most Advanced AI Factory on NVIDIA Vera Rubin
The pharmaceutical company has demonstrated how AI can transform how drugs discovery and is now scaling AI across R&D to accelerate the discovery of next-generation medicines.
Test that found source of US explosive diarrhoea outbreak was false positive, health officials say
The latest update from the US Food and Drug Administration means the exact source of the parasite is still not known.
U.S. health agency now says cyclospora finding at produce company was false positive
The U.S. Food and Drug Administration said on Sunday that laboratory experts re-reviewed sample results in the Taylor Farms Cyclospora investigation and concluded the finding should be considered a false positive.
Scientists discover a protein that protects the brain from Alzheimer’s damage
A protein called SORLA may act as a powerful defense against the toxic tau tangles involved in Alzheimer’s disease. Mice with extra SORLA had less tau accumulation, less brain atrophy, and healthier connections between neurons, while mice without it experienced more severe damage. The findings also revealed a possible drug target that could help control harmful activity in supporting brain cells.
The market for psychedelic drugs to treat mental health conditions gets a big buy signal
Eli Lilly's acquisition of psychedelic drug maker AtaiBeckley extends Big Pharma's embrace of a stigmatized class of medications for treating mental health.
Opinion | Double standard over GLP-1 drugs hits women especially hard
Women experience the effects of obesity in many ways, including heart disease, certain cancers, fertility challenges, maternal health complications, and more severe menopause symptoms.
Photos: Afrifest: Taste of Africa at Sawyer Point 2026
The festival features Africa and the Caribbean traditional drumming and cultural dance performances, music, attire and food at Sawyer Point Park.
Brandon Woodruff announces he needs season-ending shoulder surgery
Brandon Woodruff announced July 18 he needs season-ending shoulder surgery but that he's not retiring and intends to try to come back again.
Brass at the Beach brings musical excitement back to Myrtle Beach
The Drum Corps International Brass at the Beach returns to Doug Shaw Stadium on Tuesday, July 28 at 7 p.m.
Weight-loss drugs may improve job prospects and dating odds for one group
A weight-loss specialist says GLP-1 results boost confidence in job interviews and dating, but the study found no clear improvement in well-being.
GSK’s drops chronic cough drug, dampening $2bn Bellus Health bid
GSK will discontinue camlipixant’s late-stage RCC programme, though it will continue the drug’s development in two forms of IBS.
U.S. health officials zero in on source of Cyclospora outbreak
The U.S. Food and Drug Administration (FDA) is zeroing in on the source of a parasitic outbreak linked to iceberg lettuce that has sickened hundreds of people across five states.
I've been on PrEP for 11 years. Access to the HIV prevention drug is in danger.
Several interconnecting barriers continue to hinder PrEP access and exacerbate HIV prevention disparities.
Hochul drums up support for data center moratorium
The roundtable included perspective local government leaders, those in the agricultural industry, and utility advocates who stressed the need to plan ahead
The great 340B debate: Point vs. counterpoint vs. finger points
From the right come heated calls for reform if not outright overhaul of the 340B Drug Pricing Program. From the left, vociferous insistence on letting 340B be, albeit with modest tweaks and fixes. From hospitals and drug manufacturers: finger-pointing.
New Alzheimer's drug repairs DNA damage and reduces brain inflammation
A drug originally developed for spinal cord injury may offer a fresh approach to treating Alzheimer’s disease. In mouse studies, KCL-286 repaired dangerous DNA damage, reduced inflammation, and targeted multiple disease-related pathways instead of focusing on just amyloid or tau. Since it has already cleared an initial human safety trial, researchers believe it could move more quickly into Alzheimer’s clinical testing.
SF overdose deaths decline as public health officials expand treatment, drug monitoring
Overdose deaths in San Francisco have declined compared to last year, a trend local public health officials say reflects both national patterns and the city's ongoing efforts to expand treatment and other interventions.
Trump officials want to make testosterone drugs easier to prescribe. Is that a good idea?
Officials under President Donald Trump want to make it easier for men to get a prescription for testosterone, the latest shift in a decades-long debate over the benefits and risks of replacing the hormone that affects sex drive, mood and other health factors.
Boone Co. man sentenced for major drug bust at Roscoe business
A Caledonia man finds out his prison sentence after pleading guilty to trafficking fentanyl and methamphetamine in 2022.
Jillian Michaels warns against social media health advice as ‘healthmaxxing’ trend goes viral
‘Keeping It Real’ podcast host Jillian Michaels discusses the viral ‘healthmaxxing’ trend and GLP-1 drugs on ‘Fox & Friends.’
Merck’s cholesterol pill gets US FDA approval
Merck said on Thursday the U.S. FDA has approved its cholesterol pill, the first of its kind to receive the health regulator’s nod, bolstering the drugmaker’s efforts to diversify beyond its blockbuster cancer treatment Keytruda.
South Los Angeles business owner says crime, drug activity push neighborhood to breaking point
A South Los Angeles business owner says ongoing crime, drug activity and trash outside his auto body shop have created unsafe conditions.
Californian pair indicted for operating darknet drug trafficking business in U.S. and South Florida
Two suspects from California accused of running a darknet drug trafficking business throughout the U.S. and in Miami-Dade and Broward counties were indicted on Wednesday, authorities said.
Sunscreen gets an upgrade | Investors Lab
There are hundreds of brands of sunscreen available in the United States, but not one of them contains an ingredient we all need. Bemotrizinol, a highly effective, broad-spectrum chemical ultraviolet ray blocker, has been available in Europe for decades but absent from U.S. shelves. The regulatory bottleneck was driven by a 2011 U.S. Food and Drug Administration policy classifying sunscreens as drugs. While the classification remains, consumers and innovators can welcome the news that the FDA has officially approved bemotrizinol, effective August 9, 2026. Science News's Meghan Rosen provides the coverage.
Eli Lilly is reinventing the pharma business
The world’s largest drugmaker is betting big on preventive medicines—and learning from big tech
Chairman Griffith Delivers Opening Statement at Subcommittee on Health Markup of Three Bills Combatting Illicit Drug Threats
The Committee on Energy and Commerce is the oldest standing legislative committee in the U.S. House of Representatives and is vested with the broadest jurisdiction of any congressional authorizing committee.
OpenAI’s IPO Conundrum | AI & Business for July 14
Plus, Apple’s legal sparring, and Wall Street’s problem with AI drug discovery.
Weight-loss drugs didn't improve mental health or job prospects
The non-health benefits haven't been studied as closely as the health benefits.
Cleveland business trying to rebuild after alleged drunk driver crashes into building
Cleveland police said a suspected drunk driver lost control of her SUV early Sunday morning and slammed into a small business on the city’s west side.
‘The Ring’ star Daveigh Chase left an estate worth $400K after her death at 35
‘The Ring’ and ‘Lilo & Stitch’ star Daveigh Chase left an estate worth $400,000 after her death at 35 from AIDS and drug use.
Asheville wellness business owner accused of illegally prescribing GLP-1 drug
The owner of an Asheville wellness business is facing 10 felony charges after investigators accused her of diagnosing clients without a medical license in N.C.
Germany pushes through healthcare reform package despite pharma's drug discount resistance
Even as the effort has met with fierce pushback from drugmakers, trade groups and opposition parties in the country’s own government, German lawmakers late Friday voted to pass health insurance ref | Even as the effort has met with fierce pushback, German lawmakers late Friday voted to pass health insurance reforms aiming to cut healthcare costs, in part by hiking up mandatory rebates that pharmas must pay on branded medicines.
How Unaffordable is Health Care and What Can We Do About It?
For decades, the cost of medical care, prescription drugs and health insurance has consistently risen faster than general inflation and wage growth, posing financial challenges for government, businesses and people.
Integrating AI as a Human-Guided Tool in Translational Science
Peter Tummino of Nimbus Therapeutics explains how drug discovery and development experts can apply AI across targeted workflows with intention and creativity.
India seeks to quash Adani airport's nicotine pouch court challenge citing illegality, health risk
The Indian government has argued the airport sale of nicotine pouches is a "substantive violation" of drug laws and a "serious public health risk", seeking to throw out Adani Group's bid to overturn an official finding that it broke the law by selling the unlicensed products at Mumbai's airport.
GLP-1s are latest wedding trend that has serious implications
Doctors worry the drugs are becoming a wedding fad as online prescribing makes them easier to obtain.
Metaverse Market Surge: Entertainment Industry Set to Quadruple by 2032
The global metaverse in entertainment market is experiencing rapid growth, with its market size expected to soar from over USD 30.6 billion in 2026 to more...
Metaverse Market Surge: Entertainment Industry Set to Quadruple by 2032
The global metaverse in entertainment market is experiencing rapid growth, with its market size expected to soar from over USD 30.6 billion in 2026 to more than USD 121.9 billion by 2032. This expansion is driven by increasing demand for interactive digital experiences and technological investments from gaming, media, and tech sectors. Mixed Reality (MR) devices are predicted to grow the fastest, enhancing digital interactions in gaming, concerts, and sports. North America is a key player, leadi
Who’s more to blame for frustration at the pharmacy—insurers changing formularies or prescribers failing to keep up?
Patients increasingly wait for—or never receive—drug treatments deemed appropriate and timely by their doctors.
‘Quadruple threat’ John L. Beyer treats older adults’ mental health as
Beyer and his colleagues in the Department of Psychiatry are seeking to expand access to mental healthcare across both the region and the lifespan.
Emergency Suspension issued for Shively liquor store after quadruple shooting at business leaves man dead
Shively Alcoholic Beverage Control (ABC) issued an Emergency Suspension of the liquor licenses of a bar after a quadruple shooting that left a man dead.